December 20, 2018
Shionogi said on December 18 that it has concluded a licensing and investment agreement with Tetra Discovery Partners for BPN14770, a novel therapeutic agent for improving cognitive function, aiming to expand its pipeline in the field of neurology. Shionogi will...read more